Nektar Therapeutics | NKTR - Zysk Brutto





Zysk Brutto Zmiana Data
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
ALKERMES USD -61.93M 122.3M 2026-03
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 1.51B 2.41B 2025-12
Baxter International USD 362M 368M 2026-06
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 647.3M 269.6M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cipla INR 10.82B 3.33B 2026-06
Dr.Reddys Laboratories INR 5.54B 955M 2026-06
Eisai JPY -7.94B 29.94B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Exelixis USD 267.69M 15M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
MacroGenics USD -36.77M 21.84M 2026-03
Merck USD 3.42B 3.32B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD 5.18B 6.82B 2026-03
Roche Holding CHF 11.17B 6.38B 2026-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Takeda JPY 162.72B 215.2B 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Xencor USD -128.64M 124.37M 2026-03